Title : GNS561 Exhibits Potent Antiviral Activity against SARS-CoV-2 through Autophagy Inhibition - Bestion_2022_Viruses_14_132 |
Author(s) : Bestion E , Zandi K , Belouzard S , Andreani J , Lepidi H , Novello M , Rouquairol C , Baudoin JP , Rachid M , La Scola B , Mege JL , Dubuisson J , Schinazi RF , Mezouar S , Halfon P |
Ref : Viruses , 14 :132 , 2022 |
Abstract : |
PubMedSearch : Bestion_2022_Viruses_14_132 |
PubMedID: 35062337 |
Title : First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561\/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers - Harding_2022_Liver.Cancer_11_268 |
Author(s) : Harding JJ , Awada A , Roth G , Decaens T , Merle P , Kotecki N , Dreyer C , Ansaldi C , Rachid M , Mezouar S , Menut A , Bestion EN , Paradis V , Halfon P , Abou-Alfa GK , Raymond E |
Ref : Liver Cancer , 11 :268 , 2022 |
Abstract : |
PubMedSearch : Harding_2022_Liver.Cancer_11_268 |
PubMedID: 35949290 |
Title : GNS561, a clinical-stage PPT1 inhibitor, is efficient against hepatocellular carcinoma via modulation of lysosomal functions - Brun_2022_Autophagy_18_678 |
Author(s) : Brun S , Bestion E , Raymond E , Bassissi F , Jilkova ZM , Mezouar S , Rachid M , Novello M , Tracz J , Hama A , Lalmanach G , Vanderlynden L , Legouffe R , Stauber J , Schubert T , Plach MG , Courcambeck J , Drouot C , Jacquemot G , Serdjebi C , Roth G , Baudoin JP , Ansaldi C , Decaens T , Halfon P |
Ref : Autophagy , 18 :678 , 2022 |
Abstract : |
PubMedSearch : Brun_2022_Autophagy_18_678 |
PubMedID: 34740311 |
Gene_locus related to this paper: human-PPT1 |
Title : GNS561, a New Autophagy Inhibitor Active against Cancer Stem Cells in Hepatocellular Carcinoma and Hepatic Metastasis from Colorectal Cancer - Brun_2021_J.Cancer_12_5432 |
Author(s) : Brun S , Pascussi JM , Gifu EP , Bestion E , Macek-Jilkova Z , Wang G , Bassissi F , Mezouar S , Courcambeck J , Merle P , Decaens T , Pannequin J , Halfon P , Caron de Fromentel C |
Ref : J Cancer , 12 :5432 , 2021 |
Abstract : |
PubMedSearch : Brun_2021_J.Cancer_12_5432 |
PubMedID: 34405006 |
Title : GNS561 exhibits potent in vitro antiviral activity against SARS-CoV-2 through autophagy inhibition - Halfon_2020_bioRxiv__ |
Author(s) : Halfon P , Bestion E , Zandi K , Andreani J , Baudoin JP , La Scola B , Mege JL , Mezouar S , Schinazi RF |
Ref : Biorxiv , : , 2020 |
Abstract : |
PubMedSearch : Halfon_2020_bioRxiv__ |
PubMedID: 33052342 |
Title : GNS561 acts as a potent anti-fibrotic and pro-fibrolytic agent in liver fibrosis through TGF-beta1 inhibition - Bestion_2020_Ther.Adv.Chronic.Dis_11_2040622320942042 |
Author(s) : Bestion E , Jilkova ZM , Mege JL , Novello M , Kurma K , Pour STA , Lalmanach G , Vanderlynden L , Fizanne L , Bassissi F , Rachid M , Tracz J , Boursier J , Courcambeck J , Serdjebi C , Ansaldi C , Decaens T , Halfon P , Brun S |
Ref : Ther Adv Chronic Dis , 11 :2040622320942042 , 2020 |
Abstract : |
PubMedSearch : Bestion_2020_Ther.Adv.Chronic.Dis_11_2040622320942042 |
PubMedID: 32728410 |
Title : GNS561, a new lysosomotropic small molecule, for the treatment of intrahepatic cholangiocarcinoma - Brun_2019_Invest.New.Drugs_37_1135 |
Author(s) : Brun S , Bassissi F , Serdjebi C , Novello M , Tracz J , Autelitano F , Guillemot M , Fabre P , Courcambeck J , Ansaldi C , Raymond E , Halfon P |
Ref : Invest New Drugs , 37 :1135 , 2019 |
Abstract : |
PubMedSearch : Brun_2019_Invest.New.Drugs_37_1135 |
PubMedID: 30778887 |